持田製薬の株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2013/09/19 | 1,335 | 1,340 | 1,317 | 1,336 | +4 | +0.3% | 78,000 |
| 2013/09/18 | 1,315 | 1,335 | 1,314 | 1,332 | +26 | +2% | 65,000 |
| 2013/09/17 | 1,307 | 1,311 | 1,300 | 1,306 | +1 | +0.1% | 44,000 |
| 2013/09/13 | 1,311 | 1,331 | 1,296 | 1,305 | -26 | -2% | 178,000 |
| 2013/09/12 | 1,340 | 1,347 | 1,316 | 1,331 | -4 | -0.3% | 90,000 |
| 2013/09/11 | 1,322 | 1,337 | 1,322 | 1,335 | +13 | +1% | 62,000 |
| 2013/09/10 | 1,331 | 1,337 | 1,304 | 1,322 | -1 | -0.1% | 90,000 |
| 2013/09/09 | 1,320 | 1,328 | 1,294 | 1,323 | +32 | +2.5% | 88,000 |
| 2013/09/06 | 1,298 | 1,304 | 1,272 | 1,291 | +6 | +0.5% | 133,000 |
| 2013/09/05 | 1,292 | 1,292 | 1,276 | 1,285 | -13 | -1% | 63,000 |
| 2013/09/04 | 1,289 | 1,298 | 1,273 | 1,298 | +8 | +0.6% | 77,000 |
| 2013/09/03 | 1,275 | 1,294 | 1,273 | 1,290 | +21 | +1.7% | 83,000 |
| 2013/09/02 | 1,240 | 1,280 | 1,240 | 1,269 | +42 | +3.4% | 119,000 |
| 2013/08/30 | 1,259 | 1,277 | 1,208 | 1,227 | -17 | -1.4% | 206,000 |
| 2013/08/29 | 1,262 | 1,262 | 1,236 | 1,244 | -10 | -0.8% | 53,000 |
| 2013/08/28 | 1,245 | 1,255 | 1,222 | 1,254 | +2 | +0.2% | 56,000 |
| 2013/08/27 | 1,273 | 1,273 | 1,237 | 1,252 | -22 | -1.7% | 78,000 |
| 2013/08/26 | 1,268 | 1,294 | 1,253 | 1,274 | +6 | +0.5% | 65,000 |
| 2013/08/23 | 1,249 | 1,269 | 1,216 | 1,268 | +37 | +3% | 85,000 |
| 2013/08/22 | 1,232 | 1,235 | 1,222 | 1,231 | +11 | +0.9% | 32,000 |
| 2013/08/21 | 1,215 | 1,238 | 1,190 | 1,220 | +5 | +0.4% | 158,000 |
| 2013/08/20 | 1,210 | 1,251 | 1,210 | 1,215 | -19 | -1.5% | 94,000 |
| 2013/08/19 | 1,239 | 1,240 | 1,226 | 1,234 | +6 | +0.5% | 43,000 |
| 2013/08/16 | 1,229 | 1,234 | 1,220 | 1,228 | -3 | -0.2% | 51,000 |
| 2013/08/15 | 1,267 | 1,268 | 1,229 | 1,231 | -36 | -2.8% | 119,000 |
| 2013/08/14 | 1,251 | 1,280 | 1,246 | 1,267 | +16 | +1.3% | 82,000 |
| 2013/08/13 | 1,250 | 1,258 | 1,239 | 1,251 | +2 | +0.2% | 111,000 |
| 2013/08/12 | 1,255 | 1,270 | 1,247 | 1,249 | -5 | -0.4% | 28,000 |
| 2013/08/09 | 1,256 | 1,276 | 1,230 | 1,254 | +4 | +0.3% | 162,000 |
| 2013/08/08 | 1,247 | 1,278 | 1,245 | 1,250 | +8 | +0.6% | 93,000 |
| 2013/08/07 | 1,285 | 1,287 | 1,240 | 1,242 | -39 | -3% | 79,000 |
| 2013/08/06 | 1,300 | 1,300 | 1,248 | 1,281 | -19 | -1.5% | 131,000 |
| 2013/08/05 | 1,301 | 1,311 | 1,273 | 1,300 | ±0 | ±0% | 84,000 |
| 2013/08/02 | 1,287 | 1,300 | 1,273 | 1,300 | +13 | +1% | 105,000 |
| 2013/08/01 | 1,223 | 1,289 | 1,223 | 1,287 | +57 | +4.6% | 157,000 |
| 2013/07/31 | 1,238 | 1,270 | 1,216 | 1,230 | +1 | +0.1% | 139,000 |
| 2013/07/30 | 1,238 | 1,268 | 1,203 | 1,229 | -16 | -1.3% | 302,000 |
| 2013/07/29 | 1,320 | 1,346 | 1,225 | 1,245 | -49 | -3.8% | 256,000 |
| 2013/07/26 | 1,332 | 1,332 | 1,265 | 1,294 | -43 | -3.2% | 175,000 |
| 2013/07/25 | 1,388 | 1,388 | 1,318 | 1,337 | -60 | -4.3% | 133,000 |
| 2013/07/24 | 1,387 | 1,400 | 1,368 | 1,397 | +14 | +1% | 96,000 |
| 2013/07/23 | 1,375 | 1,384 | 1,359 | 1,383 | +10 | +0.7% | 115,000 |
| 2013/07/22 | 1,370 | 1,375 | 1,364 | 1,373 | +3 | +0.2% | 59,000 |
| 2013/07/19 | 1,393 | 1,393 | 1,368 | 1,370 | -25 | -1.8% | 109,000 |
| 2013/07/18 | 1,397 | 1,400 | 1,376 | 1,395 | +8 | +0.6% | 99,000 |
| 2013/07/17 | 1,386 | 1,392 | 1,363 | 1,387 | -14 | -1% | 109,000 |
| 2013/07/16 | 1,387 | 1,410 | 1,372 | 1,401 | +14 | +1% | 158,000 |
| 2013/07/12 | 1,377 | 1,403 | 1,368 | 1,387 | +12 | +0.9% | 132,000 |
| 2013/07/11 | 1,385 | 1,385 | 1,360 | 1,375 | -10 | -0.7% | 99,000 |
| 2013/07/10 | 1,400 | 1,401 | 1,371 | 1,385 | -12 | -0.9% | 151,000 |
2851～
2900
件表示中 / 3705件
類似銘柄と比較する
現在ご覧いただいている「持田薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| 持田薬 | 297,600円 | +5.1% | -7.0% | 2.69% | 19.54倍 | 0.81倍 |
|
医薬中堅。高脂血症薬、降圧薬など循環器系得意。婦人科系にも強み。消化器系育成。化粧品も |
| ジーエヌアイ | 297,100円 | +21.7% | +999.9% | 0.00% | 12.45倍 | 4.12倍 |
|
中国の特発性肺線維症で高シェア、肺線維症後続薬進出。米国で人工骨も。米中に研究開発機能 |
| ゼリア新薬 | 213,700円 | +3.1% | -6.5% | 2.25% | 9.92倍 | 1.05倍 |
|
製薬中堅。医療用は消化器系中心。滋養強壮剤「ヘパリーゼ」も柱。スイス企業買収で海外展開 |
| 杏林製薬 | 146,000円 | -2.4% | -52.3% | 3.90% | 17.47倍 | 0.62倍 |
|
医薬中堅。柱のぜんそく薬、呼吸器アレルギー薬は下期に比重。消化器領域育成。後発品も |
| 栄研化 | 200,000円 | +4.1% | -3.1% | 2.90% | 17.54倍 | 1.53倍 |
|
臨床検査薬大手。便潜血検査試薬（ＦＩＴ）はシェア７割。尿検査（ウロ）、遺伝子検査も育成 |
市場注目の銘柄
チャート関連のコラム
